Eosinophilic myocarditis
| Eosinophilic myocarditis | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | Cardiology, Immunology |
| Symptoms | Chest pain, shortness of breath, fatigue, palpitations |
| Complications | Heart failure, arrhythmias, cardiac arrest |
| Onset | |
| Duration | |
| Types | |
| Causes | Hypersensitivity, parasitic infections, autoimmune disorders |
| Risks | |
| Diagnosis | Endomyocardial biopsy, cardiac MRI, echocardiogram |
| Differential diagnosis | Myocarditis, acute coronary syndrome, pericarditis |
| Prevention | Avoidance of known allergens, management of underlying conditions |
| Treatment | Corticosteroids, immunosuppressive therapy, heart failure management |
| Medication | |
| Prognosis | Variable, depending on severity and response to treatment |
| Frequency | Rare |
| Deaths | N/A |
Eosinophilic myocarditis is a rare form of myocarditis, a condition characterized by inflammation of the heart muscle (myocardium). Unlike other forms of myocarditis, eosinophilic myocarditis involves an infiltration of eosinophils, a type of white blood cell, into the myocardium. This condition can lead to a wide range of symptoms, from mild to life-threatening, including heart failure, arrhythmias, and sudden death.
Etiology[edit]
Eosinophilic myocarditis can be caused by various factors, including drug hypersensitivity, parasitic infections, and systemic diseases such as hypereosinophilic syndrome. In some cases, the cause remains idiopathic, meaning it is unknown. Drugs commonly associated with eosinophilic myocarditis include certain antibiotics, antipsychotics, and medications used in chemotherapy.
Pathophysiology[edit]
The pathophysiology of eosinophilic myocarditis involves the infiltration of eosinophils into the myocardium. Eosinophils are part of the body's immune response and typically target parasites and play a role in allergic reactions. In eosinophilic myocarditis, these cells cause damage to the heart muscle through the release of toxic granules, leading to inflammation and necrosis of myocardial tissue. This process can impair the heart's ability to pump blood effectively, leading to symptoms of heart failure.
Clinical Presentation[edit]
Symptoms of eosinophilic myocarditis can vary widely, ranging from nonspecific symptoms such as fever, fatigue, and chest pain, to more severe manifestations like acute heart failure, cardiogenic shock, and life-threatening arrhythmias. Due to its diverse presentation, eosinophilic myocarditis can be challenging to diagnose without a high index of suspicion and appropriate diagnostic tests.
Diagnosis[edit]
Diagnosis of eosinophilic myocarditis typically involves a combination of clinical evaluation, laboratory tests, imaging studies, and endomyocardial biopsy. Laboratory tests may reveal elevated levels of eosinophils in the blood. Imaging studies, such as echocardiography and magnetic resonance imaging (MRI) of the heart, can provide information on the structure and function of the heart. However, the definitive diagnosis is usually made through an endomyocardial biopsy, which can directly demonstrate the infiltration of eosinophils into the myocardium.
Treatment[edit]
Treatment of eosinophilic myocarditis focuses on addressing the underlying cause, if known, and managing symptoms. Corticosteroids are commonly used to reduce inflammation and suppress the immune response. In cases where corticosteroids are ineffective or contraindicated, other immunosuppressive agents may be used. Management of heart failure symptoms and arrhythmias is also crucial. In severe cases, mechanical circulatory support or heart transplantation may be necessary.
Prognosis[edit]
The prognosis of eosinophilic myocarditis varies depending on the severity of the condition, the underlying cause, and the response to treatment. Early diagnosis and appropriate treatment can improve outcomes, but the condition can be fatal, especially if it leads to severe heart failure or malignant arrhythmias.

This article is a cardiovascular system stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian